Red Light Therapy

Evidence Anchor

BioHarmony 8/10

Red Light Therapy is a 7/10 BioHarmony intervention for people who want a low-risk tool for skin aging, hair density, pain, recovery, wound support, and mitochondrial signaling, provided they dose Red Light Therapy like a therapy instead of a wellness lamp. The strongest practical anchors are endpoint-specific: [Wunsch 2014](https://pubmed.ncbi.nlm.nih.gov/24286286/) supports photoaging improvements after repeated sessions, [Lanzafame 2013](https://pubmed.ncbi.nlm.nih.gov/24078483/) found a 35% hair-count increase versus 2% sham, and [Leal-Junior 2015](https://pubmed.ncbi.nlm.nih.gov/24249354/) supports exercise recovery. The weaker areas are brain, fertility, thyroid, body composition, and broad longevity, where protocols vary and trials are smaller. Red Light Therapy is best approached as consistent, targeted photobiomodulation: right wavelength, right distance, right tissue, eye protection, and enough weeks to see whether the signal is real. ✅ Best for: Adults seeking visible skin photoaging reduction over 8-12 weeks of consistent 3-5x weekly sessions. Men and women with early-stage androgenetic alopecia where scalp irradiation at 650 nm stacks additively with topical minoxidil and oral finasteride. Anyone with chronic joint pain, tendinopathy, or post-exercise recovery demands where NIR penetration at 810-850 nm delivers moderate effect-size relief. Shift workers and indoor-dominant lifestyles needing mitochondrial and circadian reinforcement. Hashimoto's patients exploring complementary interventions under endocrinologist supervision per Höfling 2013. Adults layering mitochondrial protocols (CoQ10, PQQ, urolithin A, creatine) where red light covers the photobiomodulation axis no supplement addresses. Athletes targeting recovery per Leal-Junior 2015. Post-surgical recovery and wound-healing acceleration with medical clearance per Rassi 2024 AMD meta for vision-adjacent applications. ❌ Avoid if: You have active melanoma or suspected malignant pigmented lesion in target area (relative contraindication; nitric oxide and VEGF mechanisms may promote angiogenesis to lesion). You are currently taking photosensitizing medications without prescriber consultation. You expect dramatic single-session results (the intervention is a slow tissue-level adaptation, not an acute pharmacological lever for already-optimized users). You cannot commit to consistent 3-5x weekly sessions for 8-24 weeks depending on indication. You need guideline-endorsed first-line care for hypothyroidism, depression, or cognitive decline (RLT remains adjunct or experimental for these).

Read the full BioHarmony report

My score and my verdict: one signal of three, never the whole answer.